1. Boguta L, Gradzki Z, Borges E, Maurin F, Kodjo A, Winiarczyk S. Bacterial flora in foals with upper respiratory tract infections in Poland. J Vet Med B Infect Dis Vet Public Health. 2002. 49:294–297.
Article
2. Carman S, Rosendal S, Huber L, Gyles C, McKee S, Willoughby RA, Dubovi E, Thorsen J, Lein D. Infectious agents in acute respiratory disease in horses in Ontario. J Vet Diagn Invest. 1997. 9:17–23.
Article
3. Clinical and Laboratory Standards Institute (CLSI). CSLI document M31-S1. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement. 2004. Wayne: CLSI.
4. Clinical and Laboratory Standards Institute (CLSI). CSLI document M100-S17. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. 2007. Wayne: CLSI.
5. Erskine RJ, Walker RD, Bolin CA, Bartlett PC, White DG. Trends in Antibacterial susceptibility of mastitis pathogens during a seven-year period. J Dairy Sci. 2002. 85:1111–1118.
Article
6. Fey K, Schmid P. Susceptibility of bacterial isolates from the equine respiratory tract to trimethoprim, sulfadoxine, sulfadimethoxine and combinations of these compounds. Tierarztl Prax. 1995. 23:148–154.
7. Guérin-Faublée V, Tardy F, Bouveron C, Carret G. Antimicrobial susceptibility of Streptococcus species isolated from clinical mastitis in dairy cows. Int J Antimicrob Agents. 2002. 19:219–226.
Article
8. Mumford EL, Traub-Dargatz JL, Carman J, Callan RJ, Collins JK, Goltz KL, Romm SR, Tarr SF, Salman MD. Occurrence of infectious upper respiratory tract disease and response to vaccination in horses on six sentinel premises in northern Colorado. Equine Vet J. 2003. 35:72–77.
Article